Jim Simons Midatech Pharma PLC Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.46 - $1.0 $828 - $1,800	1,800 Added 0.9%	201,537 $109,000
Q1 2022 May 13, 2022	SELL	$0.83 - $1.26 $3,198 - $4,856	-3,854 Reduced 1.89%	199,737 $176,000
Q4 2021 Feb 11, 2022	SELL	$1.05 - $1.85 $16,323 - $28,760	-15,546 Reduced 7.09%	203,591 $214,000
Q3 2021 Nov 12, 2021	BUY	$1.68 - $2.19 $14,535 - $18,947	8,652 Added 4.11%	219,137 $381,000
Q2 2021 Aug 13, 2021	SELL	$1.78 - $2.95 $250,182 - $414,628	-140,552 Reduced 40.04%	210,485 $438,000
Q1 2021 May 13, 2021	BUY	$1.92 - $3.8 $329,351 - $651,840	171,537 Added 95.56%	351,037 $748,000
Q4 2020 Feb 10, 2021	BUY	$1.77 - $2.36 $49,029 - $65,372	27,700 Added 18.25%	179,500 $336,000
Q3 2020 Nov 13, 2020	BUY	$1.29 - $4.3 $132,741 - $442,470	102,900 Added 210.43%	151,800 $275,000
Q2 2020 Aug 13, 2020	BUY	$1.25 - $3.98 $42,500 - $135,320	34,000 Added 228.19%	48,900 $67,000
Q1 2020 May 14, 2020	BUY	$1.22 - $5.2 $18,178 - $77,480	14,900 New	14,900 $27,000

Ticker MTP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,939,740
Market Cap $512K
Description
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.